Hypercholesterolemia is frequently associated with elevated Lp (a) levels, an independent
risk factor for coronary, cerebrovascular, and peripheral vascular disease. A portion of …

Cardiovascular risk is associated with high lipoprotein (a)(Lp (a)) concentrations and low
molecular weight apolipoprotein (a)(apo (a)) isoforms. We studied the relationship between …

This study demonstrates that peripheral apolipoprotein (a)[apo (a)] levels are higher in
patients with polygenic hypercholesterolemia (PH) and combined hyperlipidemia (CH) than …

Abstract Lipoprotein (a)[Lp (a)] concentrations are known to be stable under various dietary
and drug regimens. Little is known about the influence of hyperlipoproteinemia on Lp (a) …

Elevated concentrations of lipoprotein (a)(Lp [a]) in plasma are associated with premature
coronary heart disease (CHD). Lp (a) levels are largely determined by alleles at the …

Previously we quantified the amounts of immunoreactive apo [a] found in human
atherosclerotic lesions extracted sequentially with phosphate-buffered saline (PBS) and …

The apolipoprotein (a)[apo (a)] gene encodes a protein component of lipoprotein (a)[Lp (a)]
whose plasma levels vary among individuals. To study the implications of Lp (a), we …

The biosynthesis and assembly of lipoprotein (a)[Lp (a)], a marker for atherosclerotic
disease, appears to be well understood. However, information is lacking concerning the …

We studied the relation between the concentration of lipoprotein (a)[Lp (a)] in plasma,
apolipoprotein (a)[apo (a)] phenotype, and the clinical expression of coronary artery disease …

High plasma levels of lipoprotein (a)(Lp (a)) and its unique apolipoprotein, apo (a), are an
independent risk factor for cardiovascular disease. Plasma Lp (a) levels vary over a 1000 …